Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000904454-18-000066
Filing Date
2018-01-30
Accepted
2018-01-30 11:20:40
Documents
1
Period of Report
2018-01-26

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4  
1 PRIMARY DOCUMENT edgar.xml 4 5836
  Complete submission text file 0000904454-18-000066.txt   7180
Mailing Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320-1799
Business Address
Balachandran Madhavan (Reporting) CIK: 0001555508 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36294 | Film No.: 18557835

Mailing Address PAASHEUVELWEG 25A AMSTERDAM P7 1105 BP
Business Address PAASHEUVELWEG 25A AMSTERDAM P7 1105 BP 1-339-970-7000
uniQure N.V. (Issuer) CIK: 0001590560 (see all company filings)

EIN.: 000000000
SIC: 2834 Pharmaceutical Preparations